Skip to main content
. 2022 Sep 22;37(1):1–19. doi: 10.1038/s41371-022-00751-4

Fig. 5. Pathogenesis of CKD-associated cardiomyopathy.

Fig. 5

An interplay of pathophysiological processes associated with the chronic kidney disease milieu contribute to the pathogenesis of CKD-associated cardiomyopathy. These can be broadly divided into factors which increase afterload, preload, and those which result from maladaptive perturbations of intrinsic factors. AGEs advanced glycation end-products, FGF23 fibroblast growth factor 23, PTH parathyroid hormone, RAAS renin-angiotensin-aldosterone system, SNS sympathetic nervous system.